- Home
- / Jiangsu Aidea Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jiangsu Aidea Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥9
2024-10-29
Market Capitalization
¥3.8 B
2024-10-28
Revenue
¥706.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 274.1M | 340.0M | 283.7M | 251.7M | 239.5M | 403.1M | 409.9M | 706.3M |
| Cost of goods sold | 166.3M | 197.3M | 144.3M | 170.8M | 139.4M | 221.3M | 188.3M | 238.8M |
| Gross profit | 107.8M | 143.3M | 141.1M | 81.6M | 101.4M | 184.1M | 223.9M | 468.5M |
| Gross profit margin, % | 42.1% | 49.7% | 32.4% | 42.4% | 45.7% | 54.6% | 66.3% | |
| Operating expense total | 83.4M | 86.1M | 86.4M | 108.7M | 200.0M | 227.8M | 291.3M | 368.6M |
| Depreciation and amortization | 20.0M | 21.6M | 21.6M | 27.3M | 33.3M | 41.9M | 89.9M | 52.8M |
| EBITDA | 24.4M | 57.2M | 54.7M | (27.1M) | (99.4M) | (36.9M) | (57.0M) | 97.8M |
| EBITDA margin, % | 16.8% | 19.3% | -10.8% | -41.5% | -9.1% | -13.9% | 13.8% | |
| EBIT | 4.0M | 47.9M | 47.0M | (52.2M) | (148.9M) | (94.2M) | (160.0M) | 39.1M |
| EBIT margin, % | 14.1% | 16.6% | -20.7% | -62.2% | -23.4% | -39.0% | 5.5% | |
| Interest income | 4.4M | 701.0K | 2.7M | 2.7M | 1.5M | 2.5M | 2.2M | |
| Interest expense | 1.8M | 5.6M | 1.1M | 246.0K | 3.9M | 11.8M | 15.4M | 15.6M |
| Pre tax profit | 7.5M | 38.1M | 47.2M | (42.3M) | (142.4M) | (92.1M) | (166.0M) | 24.6M |
| Income tax expense | (1.1M) | 4.5M | 7.4M | (12.3M) | (18.3M) | (16.0M) | (27.2M) | 16.6M |
| Net Income | 8.6M | 33.6M | 39.8M | (30.0M) | (124.1M) | (76.1M) | (138.8M) | 8.1M |